Mylan Labs Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Mylan Labs

MYL 15.86

0.0%

Nov 19 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David Lawrence who wrote (352)	7/27/1998 12:26:00 PM
From: Rande Is	Read Replies (1) of 384

Did we think that the big boys would stand by and watch as Mylan rallies the patients to cry foul to the FDA for not allowing generic versions of some of the expensive drugs? This was a "strategy" by Mylan to draw first blood. Certainly they considered the consequences first. The big boys probably called their law firms to dig up "whatever" on Mylan to discredit them and thwart recent efforts to get more product names. If all that the hot shot lawyers could come up with was the buying of raw materials from an Italian supplier, then jacking up the price, due to no competition, then Mylan has little to worry about from the first wave of retribution. It is too bad that shareholders are so quick to lose faith. If Mylan was a good company yesterday, it will be a good one tomorrow. And rest assured there will be more accusations against Mylan by the top branded makers. Something...anything...and quick. In my opinion, the more heat that comes back on Mylan, the more effective their campaign must have been. I cannot imagine how many patients have sent letters to FDA requesting generics, but it must have been substantial to bring all this heat. Rande Is

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next